Zentek (ZTEK) Net Income towards Common Stockholders (2021 - 2026)

Zentek (ZTEK) posted quarterly Net Income towards Common Stockholders of -$2.9 million for Q1 2026, up 78.76% year-on-year from -$1.6 million in Q1 2025, and down 45.66% on a QoQ basis from -$2.0 million in Q4 2025.

Zentek (ZTEK) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Zentek (ZTEK) has reported Net Income towards Common Stockholders for 6 consecutive years, with -$2.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 78.76% year-over-year to -$2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.9 million (up 34.1% YoY) and the FY2026 annual result came in at -$7.1 million, up 2.13% from the prior year.
  • Net Income towards Common Stockholders retreated to -$2.9 million in Q1 2026 per ZTEK's latest filing, from -$2.0 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ZTEK reached as high as $2.7 million in Q3 2023 and fell as low as -$20.9 million in Q1 2023.
  • A 5-year average of -$2.4 million and a median of -$805029.4 in 2024 frame the typical range for Net Income towards Common Stockholders.
  • The largest YoY upside for Net Income towards Common Stockholders was 11635669562.62% in 2023 against a maximum downside of 14225.11% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at $0.02 in 2022, then surged by 11635669562.62% to $2.6 million in 2023, then decreased by 28.13% to $1.8 million in 2024, then slumped by 206.86% to -$2.0 million in 2025, then sank by 45.66% to -$2.9 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$2.9 million, -$2.0 million, and -$1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn -274.00 Mn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn 22.13 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn 239.00 Mn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn 147.90 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn 13.00 Mn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn -77.90 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn 112.77 Mn
10 Zentek 61.38 Mn 60.43 Mn -979,642.64 -2.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.88 Mn
Dec 31, 2025 -1.97 Mn
Sep 30, 2025 -1.74 Mn
Jun 30, 2025 -1.28 Mn
Mar 31, 2025 -13.54 Mn
Dec 31, 2024 1.85 Mn
Sep 30, 2024 1.57 Mn
Jun 30, 2024 -1.83 Mn
Mar 31, 2024 -326,038.53
Dec 31, 2023 2.57 Mn
Sep 30, 2023 2.68 Mn
Jun 30, 2023 -2.39 Mn
Mar 31, 2023 -20.92 Mn
Dec 31, 2022 0.02
Sep 30, 2022 0.04
Jun 30, 2022 -16,657.04
Dec 31, 2021 0.06
Sep 30, 2021 0.02